<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36672595</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>29</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Toxin-like Peptides from the Bacterial Cultures Derived from Gut Microbiome Infected by SARS-CoV-2-New Data for a Possible Role in the Long COVID Pattern.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">87</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11010087</ELocationID><Abstract><AbstractText>It has been 3 years since the beginning of the SARS-CoV-2 outbreak, however it is as yet little known how to care for the acute COVID-19 and long COVID patients. COVID-19 clinical manifestations are of both pulmonary and extra-pulmonary types. Extra-pulmonary ones include extreme tiredness (fatigue), shortness of breath, muscle aches, hyposmia, dysgeusia, and other neurological manifestations. In other autoimmune diseases, such as Parkinson's disease (PD) or Alzheimer's Disease (AD), it is well known that role of acetylcholine is crucial in olfactory dysfunction. We have already observed the presence of toxin-like peptides in plasma, urine, and faecal samples from COVID-19 patients, which are very similar to molecules known to alter acetylcholine signaling. After observing the production of these peptides in bacterial cultures, we have performed additional proteomics analyses to better understand their behavior and reported the extended data from our latest in vitro experiment. It seems that the gut microbiome continues to produce toxin-like peptides also after the decrease of RNA SARS-CoV-2 viral load at molecular tests. These toxicological interactions between the gut/human microbiome bacteria and the virus suggest a new scenario in the study of the clinical symptoms in long COVID and also in acute COVID-19 patients. It is discussed that in the bacteriophage similar behavior, the presence of toxins produced by bacteria continuously after viral aggression can be blocked using an appropriate combination of certain drugs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brogna</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Research, Craniomed Group Facility Srl., 20091 Bresso, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cristoni</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ISB-Ion Source &amp; Biotechnologies Srl., 20091 Bresso, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brogna</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8037-7689</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Moscati Hospital, Contrada Amoretta, 83100 Avellino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisaccia</LastName><ForeName>Domenico Rocco</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-8311-1747</Identifier><AffiliationInfo><Affiliation>Department of Research, Craniomed Group Facility Srl., 20091 Bresso, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marino</LastName><ForeName>Giuliano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Marsanconsulting Srl. Public Health Company, Via dei Fiorentini, 80133 Napoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viduto</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Long COVID-19 Foundation, Garforth, Leeds LS25 1NB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montano</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5670-9439</Identifier><AffiliationInfo><Affiliation>Andrology Unit and Service of Life Style Medicine in Uro-Andrology, Local Health Authority (ASL), 84124 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piscopo</LastName><ForeName>Marina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0560-6952</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Naples Federico II, 80126 Napoli, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">bacteriophage behavior</Keyword><Keyword MajorTopicYN="N">gut microbiome</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">toxin-like peptides</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36672595</ArticleId><ArticleId IdType="pmc">PMC9855837</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11010087</ArticleId><ArticleId IdType="pii">biomedicines11010087</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Temmam S., Vongphayloth K., Baquero E., Munier S., Bonomi M., Regnault B., Douangboubpha B., Karami Y., Chr&#xe9;tien D., Sanamxay D., et al. Bat coronaviruses related to SARS-CoV-2 and infectious for human cells. Nature. 2022;604:330&#x2013;336. doi: 10.1038/s41586-022-04532-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04532-4</ArticleId><ArticleId IdType="pubmed">35172323</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T., Hu J., et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 2020;11:1620. doi: 10.1038/s41467-020-15562-9. Erratum in Nat. Commun. 2021, 12, 2144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15562-9</ArticleId><ArticleId IdType="pmc">PMC7100515</ArticleId><ArticleId IdType="pubmed">32221306</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan B.N., Yoo H.J. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) J. Neurol. 2021;268:3059&#x2013;3071. doi: 10.1007/s00415-021-10406-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10406-y</ArticleId><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromova O.A., Torshin I.Y., Semenov V.A., Putilina M.V., Chuchalin A.G. Direct and Indirect Neurological Signs of COVID-19. Neurosci. Behav. Physiol. 2021;51:856&#x2013;866. doi: 10.1007/s11055-021-01144-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11055-021-01144-9</ArticleId><ArticleId IdType="pmc">PMC8566113</ArticleId><ArticleId IdType="pubmed">34751196</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.E., Asfour A., Sewell T.B., Hooe B., Pryce P., Earley C., Shen M.Y., Kerner-Rossi M., Thakur K.T., Vargas W.S., et al. Neurological issues in children with COVID-19. Neurosci. Lett. 2020;743:135567. doi: 10.1016/j.neulet.2020.135567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.135567</ArticleId><ArticleId IdType="pmc">PMC7831718</ArticleId><ArticleId IdType="pubmed">33352286</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.-M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Rethinavel H.S., Ravichandran S., Radhakrishnan R.K., Kandasamy M. COVID-19 and Parkinson&#x2019;s disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia. J. Chem. Neuroanat. 2021;115:101965. doi: 10.1016/j.jchemneu.2021.101965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2021.101965</ArticleId><ArticleId IdType="pmc">PMC8111887</ArticleId><ArticleId IdType="pubmed">33989761</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett M.J., Murphy J.M., Zhang J., Blair J.C., Flanigan J.L., Nawaz H., Dalrymple W.A., Sperling S.A., Patrie J., Druzgal T.J. Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease. Park. Relat. Disord. 2021;90:27&#x2013;32. doi: 10.1016/j.parkreldis.2021.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2021.07.024</ArticleId><ArticleId IdType="pubmed">34348192</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.A., Islam K., Rahman S., Alamin M. Neurobiochemical Cross-talk Between COVID-19 and Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2021;58:1017&#x2013;1023. doi: 10.1007/s12035-020-02177-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02177-w</ArticleId><ArticleId IdType="pmc">PMC7571527</ArticleId><ArticleId IdType="pubmed">33078369</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea R.C., Berlot R., Martin S.L., Craig C.E., Holmes P.S., Wright D.J., Bon J., Pirto&#x161;ek Z., Ray N.J. Quantitative EEG and cholinergic basal forebrain atrophy in Parkinson&#x2019;s disease and mild cognitive impairment. Neurobiol. Aging. 2021;106:37&#x2013;44. doi: 10.1016/j.neurobiolaging.2021.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.05.023</ArticleId><ArticleId IdType="pubmed">34233212</ArticleId></ArticleIdList></Reference><Reference><Citation>Courties A., Boussier J., Hadjadj J., Yatim N., Barnabei L., P&#xe9;r&#xe9; H., Veyer D., Kern&#xe9;is S., Carlier N., P&#xe8;ne F., et al. Regulation of the acetylcholine/&#x3b1;7nAChR anti-inflammatory pathway in COVID-19 patients. Sci. Rep. 2021;11:11886. doi: 10.1038/s41598-021-91417-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91417-7</ArticleId><ArticleId IdType="pmc">PMC8178312</ArticleId><ArticleId IdType="pubmed">34088975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopa&#x144;ska M., Batoryna M., Bartman P., Szczygielski J., Bana&#x15b;-Z&#x105;bczyk A. Disorders of the Cholinergic System in COVID-19 Era&#x2014;A Review of the Latest Research. Int. J. Mol. Sci. 2022;23:672. doi: 10.3390/ijms23020672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020672</ArticleId><ArticleId IdType="pmc">PMC8775685</ArticleId><ArticleId IdType="pubmed">35054856</ArticleId></ArticleIdList></Reference><Reference><Citation>Tizabi Y., Getachew B., Copeland R.L., Aschner M. Nicotine and the nicotinic cholinergic system in COVID-19. FEBS J. 2020;287:3656&#x2013;3663. doi: 10.1111/febs.15521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15521</ArticleId><ArticleId IdType="pmc">PMC7436654</ArticleId><ArticleId IdType="pubmed">32790936</ArticleId></ArticleIdList></Reference><Reference><Citation>Schick B., Barth E., Mayer B., Weber C.-L., Hagemeyer T., Sch&#xf6;nfeldt-Lecuona C. Prospective, observational, single-centre cohort study with an independent control group matched for age and sex aimed at investigating the significance of cholinergic activity in patients with schizophrenia: Study protocol of the CLASH-study. BMJ Open. 2021;11:e050501. doi: 10.1136/bmjopen-2021-050501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-050501</ArticleId><ArticleId IdType="pmc">PMC8689167</ArticleId><ArticleId IdType="pubmed">34930729</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima K., Abe T., Saji R., Ogawa F., Taniguchi H., Yamaguchi K., Sakai K., Nakagawa T., Matsumura R., Oi Y., et al. Serum cholinesterase associated with COVID-19 pneumonia severity and mortality. J. Infect. 2020;82:282&#x2013;327. doi: 10.1016/j.jinf.2020.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.021</ArticleId><ArticleId IdType="pmc">PMC7434637</ArticleId><ArticleId IdType="pubmed">32822684</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar J.J. Neurochemical and Neurobiological Weapons. Neurol. Clin. 2020;38:881&#x2013;896. doi: 10.1016/j.ncl.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2020.07.007</ArticleId><ArticleId IdType="pubmed">33040867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekbossynova A., Zharylgap A., Filchakova O. Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors. Molecules. 2021;26:3373. doi: 10.3390/molecules26113373.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26113373</ArticleId><ArticleId IdType="pmc">PMC8199771</ArticleId><ArticleId IdType="pubmed">34204855</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputi V., Giron M. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson&#x2019;s Disease. Int. J. Mol. Sci. 2018;19:1689. doi: 10.3390/ijms19061689.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19061689</ArticleId><ArticleId IdType="pmc">PMC6032048</ArticleId><ArticleId IdType="pubmed">29882798</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan J.F., O&#x2019;Riordan K.J., Sandhu K., Peterson V., Dinan T.G. The gut microbiome in neurological disorders. Lancet Neurol. 2020;19:179&#x2013;194. doi: 10.1016/S1474-4422(19)30356-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30356-4</ArticleId><ArticleId IdType="pubmed">31753762</ArticleId></ArticleIdList></Reference><Reference><Citation>Sochocka M., Donskow-&#x141;ysoniewska K., Diniz B.S., Kurpas D., Brzozowska E., Leszek J. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer&#x2019;s Disease&#x2014;A Critical Review. Mol. Neurobiol. 2019;56:1841&#x2013;1851. doi: 10.1007/s12035-018-1188-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1188-4</ArticleId><ArticleId IdType="pmc">PMC6394610</ArticleId><ArticleId IdType="pubmed">29936690</ArticleId></ArticleIdList></Reference><Reference><Citation>Popoff M.R. Bacterial Toxins, Current Perspectives. Toxins. 2020;12:570. doi: 10.3390/toxins12090570.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins12090570</ArticleId><ArticleId IdType="pmc">PMC7551839</ArticleId><ArticleId IdType="pubmed">32899816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri A., Travaglione S., Falzano L., Fiorentini C. Bacterial Protein Toxins: Current and Potential Clinical Use. Curr. Med. Chem. 2008;15:1116&#x2013;1125. doi: 10.2174/092986708784221430.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986708784221430</ArticleId><ArticleId IdType="pubmed">18473807</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L., He Y., Zhou Y., Liu S., Zheng B.-J., Jiang S. The spike protein of SARS-CoV&#x2014;A target for vaccine and therapeutic development. Nat. Rev. Microbiol. 2009;7:226&#x2013;236. doi: 10.1038/nrmicro2090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2090</ArticleId><ArticleId IdType="pmc">PMC2750777</ArticleId><ArticleId IdType="pubmed">19198616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiliveri S.C., Louis J.M., Ghirlando R., Bax A. Transient lipid-bound states of spike protein heptad repeats provide insights into SARS-CoV-2 membrane fusion. Sci. Adv. 2021;7:2226. doi: 10.1126/sciadv.abk2226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abk2226</ArticleId><ArticleId IdType="pmc">PMC8500521</ArticleId><ArticleId IdType="pubmed">34623907</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y., Villaruz A.E., Li M., Cha D.J., Sturdevant D.E., Otto M. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol. Microbiol. 2006;63:497&#x2013;506. doi: 10.1111/j.1365-2958.2006.05540.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2958.2006.05540.x</ArticleId><ArticleId IdType="pubmed">17176256</ArticleId></ArticleIdList></Reference><Reference><Citation>Huan Y., Kong Q., Mou H., Yi H. Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front. Microbiol. 2020;11:582779. doi: 10.3389/fmicb.2020.582779.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.582779</ArticleId><ArticleId IdType="pmc">PMC7596191</ArticleId><ArticleId IdType="pubmed">33178164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Li X., Wang Z. APD3: The antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 2016;44:D1087&#x2013;D1093. doi: 10.1093/nar/gkv1278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1278</ArticleId><ArticleId IdType="pmc">PMC4702905</ArticleId><ArticleId IdType="pubmed">26602694</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung Y., Kong B., Moon S., Yu S.-H., Chung J., Ban C., Chung W.-J., Kim S.-G., Kweon D.-H. Envelope-deforming antiviral peptide derived from influenza virus M2 protein. Biochem. Biophys. Res. Commun. 2019;517:507&#x2013;512. doi: 10.1016/j.bbrc.2019.07.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.07.088</ArticleId><ArticleId IdType="pubmed">31375212</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanki S.S., Singh P., Kashyap P., Sansi M.S., Ali S.A. Promising role of defensins peptides as therapeutics to combat against viral infection. Microb. Pathog. 2021;155:104930. doi: 10.1016/j.micpath.2021.104930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.104930</ArticleId><ArticleId IdType="pmc">PMC8084285</ArticleId><ArticleId IdType="pubmed">33933603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa S., Balkhy H., Gabere M. Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach. Adv. Bioinform. 2019;2019:6815105. doi: 10.1155/2019/6815105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/6815105</ArticleId><ArticleId IdType="pmc">PMC6634063</ArticleId><ArticleId IdType="pubmed">31354813</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna C., Cristoni S., Petrillo M., Querci M., Piazza O., Eede G.V.D. Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients. F1000Research. 2021;10:550. doi: 10.12688/f1000research.54306.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.54306.1</ArticleId><ArticleId IdType="pmc">PMC8772524</ArticleId><ArticleId IdType="pubmed">35106136</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistollato F., Petrillo M., Clerbaux L.-A., Leoni G., Ponti J., Bogni A., Brogna C., Cristoni S., Sanges R., Gyves E.M.-D., et al. Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: Possible implications for SARS-CoV-2 impact on brain development. Reprod. Toxicol. 2022;111:34&#x2013;48. doi: 10.1016/j.reprotox.2022.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reprotox.2022.04.011</ArticleId><ArticleId IdType="pmc">PMC9068247</ArticleId><ArticleId IdType="pubmed">35525527</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrillo M., Brogna C., Cristoni S., Querci M., Piazza O., Eede G.V.D. Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology. F1000Research. 2021;10:370. doi: 10.12688/f1000research.52540.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.52540.1</ArticleId><ArticleId IdType="pmc">PMC8283343</ArticleId><ArticleId IdType="pubmed">34336189</ArticleId></ArticleIdList></Reference><Reference><Citation>Arzoni A., Bernardi L.R., Cristoni S. In-source cloud ion mobility mass spectrometry. Rapid Commun. Mass Spectrom. 2015;29:690&#x2013;694. doi: 10.1002/rcm.7136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcm.7136</ArticleId><ArticleId IdType="pubmed">26212288</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristoni S., Dusi G., Brambilla P., Albini A., Conti M., Brambilla M., Bruno A., Di Gaudio F., Ferlin L., Tazzari V., et al. SANIST: Optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses. J. Mass Spectrom. 2017;52:16&#x2013;21. doi: 10.1002/jms.3895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jms.3895</ArticleId><ArticleId IdType="pubmed">27776380</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristoni S., Bernardi L.R., Larini M., Natale G., DiDomenico N., Varelli M., Conti M., Dorna I., Puccio G. Predicting and preventing intestinal dysbiosis on the basis of pharmacological gut microbiota metabolism. Rapid Commun. Mass Spectrom. 2019;33:1221&#x2013;1225. doi: 10.1002/rcm.8461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcm.8461</ArticleId><ArticleId IdType="pubmed">31013543</ArticleId></ArticleIdList></Reference><Reference><Citation>Albini A., Briga D., Conti M., Bruno A., Farioli D., Canali S., Sogno I., D&#x2019;Ambrosio G., Consonni P., Noonan D.M. SANIST: A rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers. Rapid Commun. Mass Spectrom. 2015;29:1703&#x2013;1710. doi: 10.1002/rcm.7270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcm.7270</ArticleId><ArticleId IdType="pmc">PMC5049612</ArticleId><ArticleId IdType="pubmed">26331920</ArticleId></ArticleIdList></Reference><Reference><Citation>Madama S., Falletta E., Malvandi A.M., Arzoni K., Brogna C., Varelli M., Bertelli M., Conti M., Larini M., Guidugli F., et al. q value and parent energy optimization using a low voltage ionization approach increases resolution in linear ion trap mass spectrometry. J. Biol. Mass Spectrom. 2022;57:e4876. doi: 10.1002/jms.4876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jms.4876</ArticleId><ArticleId IdType="pubmed">35941810</ArticleId></ArticleIdList></Reference><Reference><Citation>UniprotKB  Animal Toxin Annotation Project.  [(accessed on 4 October 2020)].  Available online:  https://www.uniprot.org/program/Toxins.</Citation></Reference><Reference><Citation>Arike L., Peil L. Spectral Counting Label-Free Proteomics. Methods Mol. Biol. 2014;1156:213&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">24791991</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgren D.H., Hwang S., Wu L., Han D.K. Role of spectral counting in quantitative proteomics. Expert Rev. Proteom. 2010;7:39&#x2013;53. doi: 10.1586/epr.09.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/epr.09.69</ArticleId><ArticleId IdType="pubmed">20121475</ArticleId></ArticleIdList></Reference><Reference><Citation>Jur&#x117;nas D., Fraikin N., Goormaghtigh F., Van Melderen L. Biology and evolution of bacterial toxin&#x2013;antitoxin systems. Nat. Rev. Microbiol. 2022;20:335&#x2013;350. doi: 10.1038/s41579-021-00661-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00661-1</ArticleId><ArticleId IdType="pubmed">34975154</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi K.H. SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection. FEBS Lett. 2020;594:1651&#x2013;1660. doi: 10.1002/1873-3468.13845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13845</ArticleId><ArticleId IdType="pmc">PMC7280584</ArticleId><ArticleId IdType="pubmed">32449939</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragelj J., Mroginski M.A., Ebrahimi K.H. Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2. Chembiochem. 2021;22:2946&#x2013;2950. doi: 10.1002/cbic.202100346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.202100346</ArticleId><ArticleId IdType="pmc">PMC8427076</ArticleId><ArticleId IdType="pubmed">34265150</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.-S., Kao C.-Y. Current understanding of the gut microbiota shaping mechanisms. J. Biomed. Sci. 2019;26:59. doi: 10.1186/s12929-019-0554-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0554-5</ArticleId><ArticleId IdType="pmc">PMC6702754</ArticleId><ArticleId IdType="pubmed">31434568</ArticleId></ArticleIdList></Reference><Reference><Citation>Greig N.H., Reale M., Tata A.M. New Pharmacological Approaches to the Cholinergic System: An Overview on Muscarinic Receptor Ligands and Cholinesterase Inhibitors. Recent Pat. CNS Drug Discov. 2013;8:123&#x2013;141. doi: 10.2174/1574889811308020003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574889811308020003</ArticleId><ArticleId IdType="pmc">PMC5831731</ArticleId><ArticleId IdType="pubmed">23597304</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Jeune H., Aubert I., Jourdan F., Quirion R. Comparative laminar distribution of various autoradiographic cholinergic markers in adult rat main olfactory bulb. J. Chem. Neuroanat. 1995;9:99&#x2013;112. doi: 10.1016/0891-0618(95)00070-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0891-0618(95)00070-N</ArticleId><ArticleId IdType="pubmed">8561953</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkondon M., Rocha E.S., Maelicke A., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. J. Pharmacol. Exp. Ther. 1996;278:1460&#x2013;1471.</Citation><ArticleIdList><ArticleId IdType="pubmed">8819534</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucaretchi F., Borrasca-Fernandes C.F., De Capitani E.M., Hyslop S. Consecutive envenomation of two men bitten by the same coral snake (Micrurus corallinus) Clin. Toxicol. 2019;58:132&#x2013;135. doi: 10.1080/15563650.2019.1610568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15563650.2019.1610568</ArticleId><ArticleId IdType="pubmed">31079507</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi M., Cook M., Winkel K.D. Persistent anosmia and olfactory bulb atrophy after mulga (Pseudechis australis) snakebite. J. Clin. Neurosci. 2016;29:199&#x2013;201. doi: 10.1016/j.jocn.2015.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2015.12.019</ArticleId><ArticleId IdType="pubmed">26896910</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez J.M., Calvete J.J., Habib A.G., Harrison R.A., Williams D.J., Warrell D.A. Snakebite envenoming. Nat. Rev. Dis. Prim. 2017;3:nrdp201763. doi: 10.1038/nrdp.2017.63. Erratum in Nat. Rev. Dis. Prim. 2017, 3, 17079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.63</ArticleId><ArticleId IdType="pubmed">28905944</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearn J., McGuire B., McGuire L., Richardson P. The envenomation syndrome caused by the Australian Red-bellied Black Snake Pseudechis porphyriacus. Toxicon. 2000;38:1715&#x2013;1729. doi: 10.1016/S0041-0101(00)00102-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0041-0101(00)00102-1</ArticleId><ArticleId IdType="pubmed">10858512</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis E.A., Cao J., Hsu Y.-H., Magrioti V., Kokotos G. Phospholipase A2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention. Chem. Rev. 2011;111:6130&#x2013;6185. doi: 10.1021/cr200085w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr200085w</ArticleId><ArticleId IdType="pmc">PMC3196595</ArticleId><ArticleId IdType="pubmed">21910409</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Wu L., Chen J., Dong L., Chen C., Wen Z., Hu J., Fleming I. Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets. Sig. Transduct. Target. Ther. 2021;6:94. doi: 10.1038/s41392-020-00443-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00443-w</ArticleId><ArticleId IdType="pmc">PMC7910446</ArticleId><ArticleId IdType="pubmed">33637672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragheb F., Molina-Holgado E., Cui Q.-L., Khorchid A., Liu H.-N., LaRocca J.N., Almazan G. Pharmacological and functional characterization of muscarinic receptor subtypes in developing oligodendrocytes. J. Neurochem. 2001;77:1396&#x2013;1406. doi: 10.1046/j.1471-4159.2001.00356.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00356.x</ArticleId><ArticleId IdType="pubmed">11389190</ArticleId></ArticleIdList></Reference><Reference><Citation>De Angelis F., Bernardo A., Magnaghi V., Minghetti L., Tata A.M. Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation. Dev. Neurobiol. 2012;72:713&#x2013;728. doi: 10.1002/dneu.20976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.20976</ArticleId><ArticleId IdType="pubmed">21913336</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna C., Brogna B., Bisaccia D.R., Lauritano F., Marino G., Montano L., Cristoni S., Prisco M., Piscopo M. Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages? Vaccines. 2022;10:708. doi: 10.3390/vaccines10050708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050708</ArticleId><ArticleId IdType="pmc">PMC9143435</ArticleId><ArticleId IdType="pubmed">35632464</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvelli J., Demaria O., V&#xe9;ly F., Batista L., Benmansour N.C., Fares J., Carpentier S., Thibult M.L., Morel A., Andr&#xe9; P., et al. Gut Microbiota from Patients with Mild COVID-19 Cause Alterations in Mice that Resemble Post-COVID Syndrome (Version 1) Research Square. 2022 June 22; doi: 10.21203/rs.3.rs-1756189/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1756189/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss B., Rosenblum E.N., Katz E., Grimley P.M. Rifampicin: A Specific Inhibitor of Vaccinia Virus Assembly. Nature. 1969;224:1280&#x2013;1284. doi: 10.1038/2241280a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/2241280a0</ArticleId><ArticleId IdType="pubmed">5359293</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinaga Y., Kawaratani H., Kaya D., Tsuji Y., Ozutsumi T., Furukawa M., Kitagawa K., Sato S., Nishimura N., Sawada Y., et al. Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. Int. J. Mol. Sci. 2020;21:5589. doi: 10.3390/ijms21155589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155589</ArticleId><ArticleId IdType="pmc">PMC7432739</ArticleId><ArticleId IdType="pubmed">32759852</ArticleId></ArticleIdList></Reference><Reference><Citation>Shayto R.H., Mrad R.A., Sharara A.I. Use of rifaximin in gastrointestinal and liver diseases. World J. Gastroenterol. 2016;22:6638&#x2013;6651. doi: 10.3748/wjg.v22.i29.6638.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v22.i29.6638</ArticleId><ArticleId IdType="pmc">PMC4970477</ArticleId><ArticleId IdType="pubmed">27547007</ArticleId></ArticleIdList></Reference><Reference><Citation>Llor C., P&#xe9;rez A., Carandell E., Garc&#xed;a-Sangen&#xed;s A., Rezola J., Llorente M., Gestoso S., Bob&#xe9; F., Rom&#xe1;n-Rodr&#xed;guez M., Cots J.M., et al. Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial. Aten Primaria. 2019;51:32&#x2013;39. doi: 10.1016/j.aprim.2017.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aprim.2017.08.003</ArticleId><ArticleId IdType="pmc">PMC6836912</ArticleId><ArticleId IdType="pubmed">29061311</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Toole P.W., Claesson M.J. Gut microbiota: Changes throughout the lifespan from infancy to elderly. Int. Dairy J. 2010;20:281&#x2013;291. doi: 10.1016/j.idairyj.2009.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idairyj.2009.11.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Rondanelli M. Review on microbiota and effectiveness of probiotics use in older. World J. Clin. Cases. 2015;3:156&#x2013;162. doi: 10.12998/wjcc.v3.i2.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v3.i2.156</ArticleId><ArticleId IdType="pmc">PMC4317609</ArticleId><ArticleId IdType="pubmed">25685762</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe4;kivuokko H., Tiihonen K., Tynkkynen S., Paulin L., Rautonen N. The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br. J. Nutr. 2009;103:227&#x2013;234. doi: 10.1017/S0007114509991553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114509991553</ArticleId><ArticleId IdType="pubmed">19703328</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyprian F., Sohail M.U., Abdelhafez I., Salman S., Attique Z., Kamareddine L., Al-Asmakh M. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections. Int. J. Infect. Dis. 2021;105:540&#x2013;550. doi: 10.1016/j.ijid.2021.02.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.02.071</ArticleId><ArticleId IdType="pmc">PMC7891052</ArticleId><ArticleId IdType="pubmed">33610778</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna B., Brogna C., Petrillo M., Conte A.M., Benincasa G., Montano L., Piscopo M. SARS-CoV-2 Detection in Fecal Sample from a Patient with Typical Findings of COVID-19 Pneumonia on CT but Negative to Multiple SARS-CoV-2 RT-PCR Tests on Oropharyngeal and Nasopharyngeal Swab Samples. Medicina. 2021;57:290. doi: 10.3390/medicina57030290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57030290</ArticleId><ArticleId IdType="pmc">PMC8003654</ArticleId><ArticleId IdType="pubmed">33804646</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang I.K., Iwasaki A. Control of antiviral immunity by pattern recognition and the microbiome. Immunol. Rev. 2012;245:209&#x2013;226. doi: 10.1111/j.1600-065X.2011.01073.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2011.01073.x</ArticleId><ArticleId IdType="pmc">PMC3659816</ArticleId><ArticleId IdType="pubmed">22168422</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.-J., Ni Z.-Y., Hu Y., Liang W.-H., Ou C.-Q., He J.-X. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Dakshinamoorthy M., Venkatesh A., Arumugam K. A literature review on dental caries vaccine-A prevention strategy. Indian J. Public Health Res. Dev. 2019;10:3041&#x2013;3043.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>